These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

82 related items for PubMed ID: 542176

  • 21. Failure of induction of liver microsomal enzymes by tolbutamide in maturity-onset diabetics.
    Redman DR, Prescott LF.
    Diabetes; 1973 Mar; 22(3):210-1. PubMed ID: 4689295
    [No Abstract] [Full Text] [Related]

  • 22. Quinidine-digoxin interaction: are the pharmacokinetics of both drugs altered?
    Rameis H.
    Int J Clin Pharmacol Ther Toxicol; 1985 Mar; 23(3):145-53. PubMed ID: 3997300
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Glyburide and glipizide, second-generation oral sulfonylurea hypoglycemic agents.
    Prendergast BD.
    Clin Pharm; 1984 Mar; 3(5):473-85. PubMed ID: 6435940
    [Abstract] [Full Text] [Related]

  • 31. The effect of different oral anticoagulants on diphenylhydantoin (DPH) and tolbutamide metabolism.
    Skovsted L, Kristensen M, Hansen M, Siersbaek-Nielsen K.
    Acta Med Scand; 1976 Mar; 199(6):513-5. PubMed ID: 59517
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. [Investigations of the mode action of buformin using a 3H-labelled glucose in people with a healthy metabolism (author's transl)].
    Bottermann P, Schweigart U, Ermler R.
    Med Klin; 1976 Sep 03; 71(36):1423-8. PubMed ID: 958105
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Genetic control of tolbutamide metabolism in humans.
    Scott J, Henderson AD, Poffenbarger PL.
    Adv Exp Med Biol; 1979 Sep 03; 119():361-70. PubMed ID: 495292
    [No Abstract] [Full Text] [Related]

  • 39. Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance.
    Zilly W, Breimer DD, Richter E.
    Eur J Clin Pharmacol; 1975 Dec 19; 9(2-3):219-27. PubMed ID: 1233266
    [Abstract] [Full Text] [Related]

  • 40. The effect of sulphinpyrazone on oxidative drug metabolism in man: inhibition of tolbutamide elimination.
    Miners JO, Foenander T, Wanwimolruk S, Gallus AS, Birkett DJ.
    Eur J Clin Pharmacol; 1982 Dec 19; 22(4):321-6. PubMed ID: 7106168
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.